BACKGROUND: Coping Effectively with Heart Failure (COPE-HF) is an ongoing randomized clinical trial funded by the National Institutes of Health to evaluate if a coping skills training (CST) intervention will result in improved health status and quality of life as well as reduced mortality and hospitalizations compared with a heart failure education (HFE) intervention. METHODS AND RESULTS: Two hundred heart failure (HF) patients recruited from the Duke University Medical Center and the University of North Carolina Hospital system will be randomized to a CST intervention (16 weekly 30-minute telephone counseling sessions including motivational interviewing and individually tailored cognitive behavioral therapy) or to an HFE intervention (16 weekly 30-minute telephone sessions including education and symptom monitoring). Primary outcomes will include postintervention effects on HF biomarkers (B-type natriuretic peptide, ejection fraction) and quality of life, as well as long-term clinical outcomes (hospitalizations and death). Secondary analyses will include an evaluation of treatment effects across subpopulations, and potential mechanisms by which CST may improve clinical outcomes. CONCLUSIONS: COPE-HF is a proof-of-concept study that should provide important insights into the health benefits of a CST intervention designed to enhance HF self-management, improve health behaviors, and reduce psychologic distress.
RCT Entities:
BACKGROUND: Coping Effectively with Heart Failure (COPE-HF) is an ongoing randomized clinical trial funded by the National Institutes of Health to evaluate if a coping skills training (CST) intervention will result in improved health status and quality of life as well as reduced mortality and hospitalizations compared with a heart failure education (HFE) intervention. METHODS AND RESULTS: Two hundred heart failure (HF) patients recruited from the Duke University Medical Center and the University of North Carolina Hospital system will be randomized to a CST intervention (16 weekly 30-minute telephone counseling sessions including motivational interviewing and individually tailored cognitive behavioral therapy) or to an HFE intervention (16 weekly 30-minute telephone sessions including education and symptom monitoring). Primary outcomes will include postintervention effects on HF biomarkers (B-type natriuretic peptide, ejection fraction) and quality of life, as well as long-term clinical outcomes (hospitalizations and death). Secondary analyses will include an evaluation of treatment effects across subpopulations, and potential mechanisms by which CST may improve clinical outcomes. CONCLUSIONS: COPE-HF is a proof-of-concept study that should provide important insights into the health benefits of a CST intervention designed to enhance HF self-management, improve health behaviors, and reduce psychologic distress.
Authors: Thomas Rutledge; Veronica A Reis; Sarah E Linke; Barry H Greenberg; Paul J Mills Journal: J Am Coll Cardiol Date: 2006-09-26 Impact factor: 24.094
Authors: Wayne Rosamond; Katherine Flegal; Gary Friday; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Michael Ho; Virginia Howard; Brett Kissela; Bret Kissela; Steven Kittner; Donald Lloyd-Jones; Mary McDermott; James Meigs; Claudia Moy; Graham Nichol; Christopher J O'Donnell; Veronique Roger; John Rumsfeld; Paul Sorlie; Julia Steinberger; Thomas Thom; Sylvia Wasserthiel-Smoller; Yuling Hong Journal: Circulation Date: 2006-12-28 Impact factor: 29.690
Authors: James A Blumenthal; Michael A Babyak; Francis J Keefe; R Duane Davis; Rick A Lacaille; Robert M Carney; Kenneth E Freedland; Elbert Trulock; Scott M Palmer Journal: J Consult Clin Psychol Date: 2006-06
Authors: Andrew Sherwood; James A Blumenthal; Ranak Trivedi; Kristy S Johnson; Christopher M O'Connor; Kirkwood F Adams; Carla Sueta Dupree; Robert A Waugh; Daniel R Bensimhon; Laura Gaulden; Robert H Christenson; Gary G Koch; Alan L Hinderliter Journal: Arch Intern Med Date: 2007-02-26
Authors: Sarwat I Chaudhry; Christopher O Phillips; Simon S Stewart; Barbara Riegel; Jennifer A Mattera; Anthony F Jerant; Harlan M Krumholz Journal: J Card Fail Date: 2007-02 Impact factor: 5.712
Authors: Ulrik Wisløff; Asbjørn Støylen; Jan P Loennechen; Morten Bruvold; Øivind Rognmo; Per Magnus Haram; Arnt Erik Tjønna; Jan Helgerud; Stig A Slørdahl; Sang Jun Lee; Vibeke Videm; Anja Bye; Godfrey L Smith; Sonia M Najjar; Øyvind Ellingsen; Terje Skjaerpe Journal: Circulation Date: 2007-06-04 Impact factor: 29.690
Authors: Andrew Sherwood; James A Blumenthal; Gary G Koch; Benson M Hoffman; Lana L Watkins; Patrick J Smith; Christopher M O'Connor; Kirkwood F Adams; Joseph G Rogers; Carla Sueta; Patricia P Chang; Kristy S Johnson; Jeanne Schwartz; Alan L Hinderliter Journal: Circ Heart Fail Date: 2017-01 Impact factor: 8.790
Authors: James A Blumenthal; Yidan Zhu; Gary G Koch; Patrick J Smith; Lana L Watkins; Alan L Hinderliter; Benson M Hoffman; Joseph G Rogers; Patricia P Chang; Christopher O'Connor; Kristy S Johnson; Andrew Sherwood Journal: Health Psychol Date: 2019-04-18 Impact factor: 4.267
Authors: Nicola J Paine; Alan L Hinderliter; James A Blumenthal; Kirkwood F Adams; Carla A Sueta; Patricia P Chang; Christopher M O'Connor; Andrew Sherwood Journal: Am Heart J Date: 2016-05-20 Impact factor: 4.749
Authors: Robert P Nolan; Ada Ym Payne; Heather Ross; Michel White; Bianca D'Antono; Sammy Chan; Susan I Barr; Femida Gwadry-Sridhar; Anil Nigam; Sylvie Perreault; Michael Farkouh; Michael McDonald; Jack Goodman; Scott Thomas; Shelley Zieroth; Debra Isaac; Paul Oh; Miroslaw Rajda; Maggie Chen; Gunther Eysenbach; Sam Liu; Ahmad Zbib Journal: JMIR Res Protoc Date: 2014-01-30